Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D. Sermer

Clinical Significance and Outcomes in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Harboring Extra Copies [Ec] and/or Translocations [Tl] of Myc, Bcl2, and Bcl6

Hematological Oncology

English

Safety and Early Data From a Phase Ii Trial of Pembrolizumab (Pem) and Entinostat (Ent) in Relapsed and Refractory (R/R) Hodgkin Lymphoma (Hl) and Follicular Lymphoma (Fl)

Hematological Oncology

English

Related publications

Outcome of Patients With C-Myc Rearranged Diffuse Large B Cell Lymphoma Associated or Not With Bcl2 and/or Bcl6 Rearrangement: A Multicentric and Retrospective Study

Hematological Oncology

English

MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

PLoS ONE

Multidisciplinary

2014

English

Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

BCL2 mRNA or Protein Abundance Is Superior to Gene Rearrangement Status in Predicting Clinical Outcomes in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology

English

Detailed Molecular Analysis and Evaluation of Prognosis in Cases With High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

British Journal of Haematology

Hematology

2018

English

Targeting MYC Activity in Double-Hit Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements With Epigenetic Bromodomain Inhibitors

Journal of Hematology and Oncology

English

Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)

Hematological Oncology

English

Unfavorable Prognostic Impact of MYC Increased Copy Number (ICN) in Patients With Diffuse Large B-Cell (DLBCL) and High-Grade Lymphoma Treated With Immunochemotherapy

Hematological Oncology

English

A Retrospective Analysis of Real-World Outcomes of Chinese Elder Patients With Diffuse Large B Cell Lymphoma (Dlbcl)

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D. Sermer

Clinical Significance and Outcomes in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Harboring Extra Copies [Ec] and/or Translocations [Tl] of Myc, Bcl2, and Bcl6

Safety and Early Data From a Phase Ii Trial of Pembrolizumab (Pem) and Entinostat (Ent) in Relapsed and Refractory (R/R) Hodgkin Lymphoma (Hl) and Follicular Lymphoma (Fl)

Related publications

Outcome of Patients With C-Myc Rearranged Diffuse Large B Cell Lymphoma Associated or Not With Bcl2 and/or Bcl6 Rearrangement: A Multicentric and Retrospective Study

MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma

BCL2 mRNA or Protein Abundance Is Superior to Gene Rearrangement Status in Predicting Clinical Outcomes in Patients With Diffuse Large B-Cell Lymphoma

Detailed Molecular Analysis and Evaluation of Prognosis in Cases With High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

Targeting MYC Activity in Double-Hit Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements With Epigenetic Bromodomain Inhibitors

Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)

Unfavorable Prognostic Impact of MYC Increased Copy Number (ICN) in Patients With Diffuse Large B-Cell (DLBCL) and High-Grade Lymphoma Treated With Immunochemotherapy

A Retrospective Analysis of Real-World Outcomes of Chinese Elder Patients With Diffuse Large B Cell Lymphoma (Dlbcl)